Aurobindo Pharma arm Acrotech Biopharma launches ADQUEY in US dermatology market

Drug firm Aurobindo Pharma Ltd on Wednesday (September 30) said its biopharmaceutical arm Acrotech Biopharma Inc. has launched ADQUEY (difamilast 1%) ointment in the US for the treatment of mild-to-moderate atopic dermatitis in adults and paediatric patients aged 2 years and older. ADQUEY is a non-steroidal topical phosphodiesterase-4 (PDE4) inhibitor. The product will compete in…

Read More

FIIs offload nearly ₹25,500 crore in 3 days as market fails to hold recovery

Foreign institutional investors (FIIs) stepped up selling in Indian equities on Wednesday, offloading shares worth ₹10,148.41 crore on a provisional basis, according to exchange data. Domestic institutional investors (DIIs), meanwhile, continued to provide strong support, recording net purchases of ₹11,271.73 crore. FIIs bought equities worth ₹14,967.82 crore during the session but sold shares worth ₹25,116.23…

Read More

Waaree Energies starts commercial production on 1.10 GW solar inverter line in Gujarat

Mumbai-based battery manufacturing company Waaree Energies Ltd on Wednesday (September 30) said its wholly owned subsidiary Waaree Power Private Ltd has commenced commercial production of a new solar inverter manufacturing line with an annual installed capacity of 1.10 GW. Commercial production on the new line commenced at 11:00 a.m. on Wednesday. Following the commissioning of…

Read More

Highway Infrastructure signs ₹221 crore toll operations contract for Gorakhpur Link Expressway

Highway Infrastructure Ltd on Wednesday (September 30) said it has entered into a contract agreement worth ₹220.66 crore with the Uttar Pradesh Expressways Industrial Development Authority (UPEIDA) for collection of user fees and operation of toll plazas on the Gorakhpur Link Expressway. The contract agreement was signed on September 30, following the Letter of Acceptance…

Read More